Measuring quality of life of patients with different clinical types of psoriasis using the SF-36

The British Journal of Dermatology
F SampognaIDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators

Abstract

Different specific and generic instruments are used to evaluate quality of life in dermatology, but their interrelationship is not well known. To describe the quality of life in patients with different clinical types of psoriasis using the 36-item short form of the Medical Outcomes Study questionnaire (SF-36), and to study its correlation with dermatology-specific instruments. We conducted a cross-sectional study of 380 inpatients with psoriasis. SF-36 mean scores were compared with the norms for medical and psychiatric disorders. Quality of life was also measured by both dermatology-specific (Skindex-29 and Dermatology Life Quality Index, DLQI) and psoriasis-specific instruments (Psoriasis Disability Index, PDI, and the Impact of Psoriasis Questionnaire, IPSO). A specific (Psoriasis Life Stress Inventory, PLSI) and a generic (12-item General Health Questionnaire, GHQ-12) measure of psychological distress was also used. A cluster analysis was performed to study the relationship among the different questionnaires. Our study population showed SF-36 physical health scores similar to minor medical conditions (e.g. physical functioning 79 for psoriasis, 80 for minor medical conditions, and 57 for severe medical conditions), but ment...Continue Reading

References

Jan 1, 1978·Dermatologica·T Fredriksson, U Pettersson
Jan 1, 1987·Social Psychiatry. Sozialpsychiatrie. Psychiatrie Sociale·C BellantuonoM Tansella
Jan 1, 1987·Clinical and Experimental Dermatology·A Y Finlay, S E Kelly
Nov 1, 1972·British Journal of Haematology·A Goldberg
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·D BennettE A Boyse
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Jan 1, 1996·The Journal of Investigative Dermatology·S R FeldmanL Nurre
Oct 12, 1996·BMJ : British Medical Journal·P O'Neill, P Kelly
Mar 1, 1997·Journal of the American Academy of Dermatology·K E McKenna, R S Stern
Nov 17, 1998·Journal of Clinical Epidemiology·G Apolone, P Mosconi
Dec 22, 1998·Seminars in Cutaneous Medicine and Surgery·A Y Finlay
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
May 22, 2001·The British Journal of Dermatology·C R TouwA Y Finlay
Feb 9, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·Damiano AbeniMary Margaret Chren
Sep 25, 2002·Journal of the American Academy of Dermatology·Stefan C WeissEzekiel J Emanuel
Mar 8, 2003·Archives of Dermatology·Francesca SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Vera M HeydendaelMenno A de Rie
Apr 17, 2004·The Journal of Investigative Dermatology·Francesca SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators
Sep 21, 2004·The British Journal of Dermatology·F SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences Investigators

❮ Previous
Next ❯

Citations

Nov 17, 2010·Pediatric Dermatology·Ayhan BilgicEmine Zinnur Kılıç
May 26, 2012·Health and Quality of Life Outcomes·Esteban DaudenNuria Lara
Oct 27, 2006·Expert Opinion on Emerging Drugs·Gino A Vena, Nicoletta Cassano
Feb 19, 2016·Clinical and Experimental Dermatology·J F MerolaA A Qureshi
Jan 31, 2012·Dermatologic Clinics·Deshan F SebaratnamDédée F Murrell
Jan 31, 2012·Dermatologic Clinics·Seema P Kini, Laura K DeLong
Dec 6, 2011·Clinics in Dermatology·Deshan F SebaratnamDédée F Murrell
Mar 15, 2011·Journal of the American Academy of Dermatology·Rachel KleinVictoria P Werth
Oct 12, 2010·Annales de dermatologie et de vénéréologie·E RedonJ-L Schmutz
Mar 18, 2009·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Charlène E U OduberChantal M A M van der Horst
Apr 16, 2009·Experimental Dermatology·Christiane GuinotUNKNOWN French Psoriasis Group
Mar 6, 2008·Dermatologic Therapy·Judith HongJohn Koo
Jun 1, 2007·Dermatologic Therapy·Heidi T JacobePaul R Bergstresser
Jan 6, 2009·The British Journal of Dermatology·F SampognaD Abeni
Aug 22, 2013·The Journal of Dermatology·Zorica Sojević TimotijevićJanko Janković
Sep 28, 2012·The British Journal of Dermatology·S TabolliUNKNOWN Italian Writing Exercise Study Group
Mar 1, 2011·The Journal of Dermatology·Berna AksoyNilgün Atakan
Jun 30, 2011·The British Journal of Dermatology·Y-W YangH-C Lin
Jun 18, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·J LatreilleC Guinot
Jul 30, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·K-Y WangZ-P Zhang
Jan 28, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·S TabolliD Abeni
Apr 21, 2016·Journal of Psychosomatic Research·Uwe Matterne, Christian Apfelbacher
Apr 6, 2013·International Journal of Dermatology·Nejib Doss
Jan 15, 2015·The Journal of Dermatology·Chau Yee NgYu-Huei Huang
May 15, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·V BronsardJ-P Ortonne
Jan 28, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·A Molina-LeyvaJ J Jimenez-Moleon
Aug 22, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·F AyalaC Potenza
May 22, 2016·Journal of the American Academy of Dermatology·Bruce StroberPaul Klekotka
Oct 30, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·L PuigG S Ramakrishna
Jan 11, 2017·Journal of the American Academy of Dermatology·Marlena HawroTomasz Hawro
Jun 9, 2012·Dermatology : International Journal for Clinical and Investigative Dermatology·K A P MeeuwisM M van Rossum
Sep 20, 2018·The Journal of Dermatology·Hideki FujitaUNKNOWN Japanese Dermatological Association Guidelines Development Committee for the Guidelines for the Management and Treatment of
Dec 1, 2007·The British Journal of Dermatology·M Halabi-TawilS Aractingi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Dermatology
F SampognaItalian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group
Journal of the American Academy of Dermatology
S R RappD M Reboussin
BMJ : British Medical Journal
C H Smith, J N W N Barker
© 2022 Meta ULC. All rights reserved